Article

OBJECTIVE: To evaluate the impact and long-term benefit of a brief 1(1/2)-day
fibromyalgia treatment program. DESIGN: We assessed 6-12-mo outcome of 521
participants who underwent a 1(1/2)-day interdisciplinary fibromyalgia treatment
program in a tertiary medical center. We administered three self-reported
instruments: the Fibromyalgia Impact Questionnaire, the Short Form-36 Health
Status Questionnaire, and a satisfaction survey, at baseline, and 6-12 mos after
completing the fibromyalgia treatment program. The difference in the Fibromyalgia
Impact Questionnaire and Short Form-36 scores before and after the fibromyalgia
treatment program was the main outcome measure. RESULTS: Compared with baseline,
the Fibromyalgia Impact Questionnaire total score was decreased by a mean (SD) of
7.2 (17.7) points at follow-up (P < 0.001). All Fibromyalgia Impact Questionnaire
subscales improved significantly at follow-up (all P < 0.001), except depression
score (P = 0.67). The Short Form-36 scores improved significantly in all areas at
follow-up (all P < 0.001), except general health perception (P = 0.58) and role
emotional (P = 0.13). CONCLUSIONS: A brief 1(1/2)-day fibromyalgia treatment
program improves symptoms and quality of life in patients with fibromyalgia for
6-12 mos. Further clinical investigations are needed to compare this fibromyalgia
treatment program with other programs and interventions.

Langue : ANGLAIS